Correction to: Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US
Crossref DOI link: https://doi.org/10.1007/s40273-023-01263-w
Published Online: 2023-03-16
Published Print: 2023-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Goswami, Hardik
Alsumali, Adnan
Jiang, Yiling
Schindler, Matthias
Duke, Elizabeth R.
Cohen, Joshua
Briggs, Andrew
Puenpatom, Amy
Text and Data Mining valid from 2023-03-16
Version of Record valid from 2023-03-16
Article History
First Online: 16 March 2023